PRODUCTID	PRODUCTNDC	PRODUCTTYPENAME	PROPRIETARYNAME	PROPRIETARYNAMESUFFIX	NONPROPRIETARYNAME	DOSAGEFORMNAME	ROUTENAME	STARTMARKETINGDATE	ENDMARKETINGDATE	MARKETINGCATEGORYNAME	APPLICATIONNUMBER	LABELERNAME	SUBSTANCENAME	ACTIVE_NUMERATOR_STRENGTH	ACTIVE_INGRED_UNIT	PHARM_CLASSES	DEASCHEDULE
0002-1200_90cd7556-b011-4f13-bd57-cc0f162267ee	0002-1200	HUMAN PRESCRIPTION DRUG	Amyvid		Florbetapir F 18	INJECTION, SOLUTION	INTRAVENOUS	20120601		NDA	NDA202008	Eli Lilly and Company	FLORBETAPIR F-18	51	mCi/mL	Radioactive Diagnostic Agent [EPC],Positron Emitting Activity [MoA]
0002-1407_e7af3676-cd9d-4c30-b127-9f6c46ff1589	0002-1407	HUMAN PRESCRIPTION DRUG	Quinidine Gluconate		Quinidine Gluconate	SOLUTION	INTRAVENOUS	19510301		NDA	NDA007529	Eli Lilly and Company	QUINIDINE GLUCONATE	80	mg/mL	Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA]
0002-1433_dc50cfc7-a644-42c1-aadc-4df7b8db8925	0002-1433	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20141107		BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	.75	mg/.5mL
0002-1434_dc50cfc7-a644-42c1-aadc-4df7b8db8925	0002-1434	HUMAN PRESCRIPTION DRUG	Trulicity		Dulaglutide	INJECTION, SOLUTION	SUBCUTANEOUS	20141107		BLA	BLA125469	Eli Lilly and Company	DULAGLUTIDE	1.5	mg/.5mL
0002-1975_9220c68d-a22a-40f6-8269-b70a079948db	0002-1975	HUMAN PRESCRIPTION DRUG	AXIRON		testosterone	SOLUTION	TOPICAL	20101201		NDA	NDA022504	Eli Lilly and Company	TESTOSTERONE	30	mg/1.5mL	Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient]	CIII
0002-3004_77661866-2f7c-4b90-8866-dce57ebb87bb	0002-3004	HUMAN PRESCRIPTION DRUG	Prozac	Weekly	Fluoxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20010316		NDA	NDA021235	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE	90	mg/1	Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3227_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3227	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20030110		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	10	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3228_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3228	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20030110		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	25	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3229_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3229	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20030110		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	40	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3230_84aabbda-2d4d-4535-8438-0165f8f2e278	0002-3230	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20070409		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 3	mg/1; mg/1	Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3231_84aabbda-2d4d-4535-8438-0165f8f2e278	0002-3231	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20040119		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 6	mg/1; mg/1	Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3232_84aabbda-2d4d-4535-8438-0165f8f2e278	0002-3232	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20040119		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	25; 12	mg/1; mg/1	Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3233_84aabbda-2d4d-4535-8438-0165f8f2e278	0002-3233	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20040119		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 6	mg/1; mg/1	Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3234_84aabbda-2d4d-4535-8438-0165f8f2e278	0002-3234	HUMAN PRESCRIPTION DRUG	Symbyax		Olanzapine and Fluoxetine hydrochloride	CAPSULE	ORAL	20040119		NDA	NDA021520	Eli Lilly and Company	FLUOXETINE HYDROCHLORIDE; OLANZAPINE	50; 12	mg/1; mg/1	Atypical Antipsychotic [EPC],Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3235_64aad694-57dd-45b8-b57f-f66cb977e347	0002-3235	HUMAN PRESCRIPTION DRUG	Cymbalta		Duloxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20040824		NDA	NDA021427	Eli Lilly and Company	DULOXETINE HYDROCHLORIDE	20	mg/1	Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3238_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3238	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20030110		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	18	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3239_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3239	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20030110		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3240_64aad694-57dd-45b8-b57f-f66cb977e347	0002-3240	HUMAN PRESCRIPTION DRUG	Cymbalta		Duloxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20040824		NDA	NDA021427	Eli Lilly and Company	DULOXETINE HYDROCHLORIDE	30	mg/1	Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-3250_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3250	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20060301		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	80	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3251_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-3251	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	CAPSULE	ORAL	20060301		NDA	NDA021411	Eli Lilly and Company	ATOMOXETINE HYDROCHLORIDE	100	mg/1	Norepinephrine Reuptake Inhibitor [EPC],Norepinephrine Uptake Inhibitors [MoA]
0002-3270_64aad694-57dd-45b8-b57f-f66cb977e347	0002-3270	HUMAN PRESCRIPTION DRUG	Cymbalta		Duloxetine hydrochloride	CAPSULE, DELAYED RELEASE	ORAL	20100115		NDA	NDA021427	Eli Lilly and Company	DULOXETINE HYDROCHLORIDE	60	mg/1	Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
0002-4112_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4112	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19970623		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	2.5	mg/1	Atypical Antipsychotic [EPC]
0002-4115_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4115	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]
0002-4116_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4116	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	7.5	mg/1	Atypical Antipsychotic [EPC]
0002-4117_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4117	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	19961001		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]
0002-4165_80058de0-c2a4-4009-9f8d-e32478ccc93e	0002-4165	HUMAN PRESCRIPTION DRUG	Evista		Raloxifene hydrochloride	TABLET	ORAL	19980106		NDA	NDA020815	Eli Lilly and Company	RALOXIFENE HYDROCHLORIDE	60	mg/1	Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA]
0002-4415_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4415	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	20000110		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]
0002-4420_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4420	HUMAN PRESCRIPTION DRUG	Zyprexa		Olanzapine	TABLET	ORAL	20010301		NDA	NDA020592	Eli Lilly and Company	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]
0002-4453_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4453	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20000601		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	5	mg/1	Atypical Antipsychotic [EPC]
0002-4454_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4454	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20000601		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	10	mg/1	Atypical Antipsychotic [EPC]
0002-4455_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4455	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20010901		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	15	mg/1	Atypical Antipsychotic [EPC]
0002-4456_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-4456	HUMAN PRESCRIPTION DRUG	ZYPREXA	Zydis	Olanzapine	TABLET, ORALLY DISINTEGRATING	ORAL	20010901		NDA	NDA021086	Eli Lilly and Company	OLANZAPINE	20	mg/1	Atypical Antipsychotic [EPC]
0002-4462_8c483369-00a0-435b-9385-64f9a3f6b279	0002-4462	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20031126		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	5	mg/1	Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
0002-4463_8c483369-00a0-435b-9385-64f9a3f6b279	0002-4463	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20031126		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	10	mg/1	Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
0002-4464_8c483369-00a0-435b-9385-64f9a3f6b279	0002-4464	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20031126		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	20	mg/1	Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
0002-4465_8c483369-00a0-435b-9385-64f9a3f6b279	0002-4465	HUMAN PRESCRIPTION DRUG	Cialis		Tadalafil	TABLET, FILM COATED	ORAL	20080107		NDA	NDA021368	Eli Lilly and Company	TADALAFIL	2.5	mg/1	Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
0002-4770_1814c9b1-201a-4389-9a60-0ae9cc5006af	0002-4770	HUMAN PRESCRIPTION DRUG	Livalo		pitavastatin calcium	TABLET, FILM COATED	ORAL	20100515		NDA	NDA022363	Eli Lilly and Company	PITAVASTATIN CALCIUM	1	mg/1	HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
0002-4771_1814c9b1-201a-4389-9a60-0ae9cc5006af	0002-4771	HUMAN PRESCRIPTION DRUG	Livalo		pitavastatin calcium	TABLET, FILM COATED	ORAL	20100515		NDA	NDA022363	Eli Lilly and Company	PITAVASTATIN CALCIUM	2	mg/1	HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
0002-4772_1814c9b1-201a-4389-9a60-0ae9cc5006af	0002-4772	HUMAN PRESCRIPTION DRUG	Livalo		pitavastatin calcium	TABLET, FILM COATED	ORAL	20100515		NDA	NDA022363	Eli Lilly and Company	PITAVASTATIN CALCIUM	4	mg/1	HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
0002-5121_13e7ccaa-0643-484a-add7-0ccc2fb10246	0002-5121	HUMAN PRESCRIPTION DRUG	Effient		Prasugrel hydrochloride	TABLET, FILM COATED	ORAL	20120301		NDA	NDA022307	Eli Lilly and Company	PRASUGREL HYDROCHLORIDE	5	mg/1	Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]
0002-5123_13e7ccaa-0643-484a-add7-0ccc2fb10246	0002-5123	HUMAN PRESCRIPTION DRUG	Effient		Prasugrel hydrochloride	TABLET, FILM COATED	ORAL	20120301		NDA	NDA022307	Eli Lilly and Company	PRASUGREL HYDROCHLORIDE	10	mg/1	Decreased Platelet Aggregation [PE],P2Y12 Platelet Inhibitor [EPC],P2Y12 Receptor Antagonists [MoA]
0002-5800_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-5800	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	KIT	ORAL	20140831		NDA	NDA021411	Eli Lilly and Company
0002-5801_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-5801	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	KIT	ORAL	20140831		NDA	NDA021411	Eli Lilly and Company
0002-5802_00768dba-4c2a-41de-b0cc-9d420862a2d6	0002-5802	HUMAN PRESCRIPTION DRUG	Strattera		Atomoxetine hydrochloride	KIT	ORAL	20140831		NDA	NDA021411	Eli Lilly and Company
0002-7140_da423d8f-0105-410f-8384-43b5df8603b4	0002-7140	HUMAN PRESCRIPTION DRUG	REOPRO		abciximab	INJECTION, SOLUTION	INTRAVENOUS	19931216		BLA	BLA103575	Eli Lilly and Company	ABCIXIMAB	2	mg/mL
0002-7335_fcd69bec-865d-4403-882a-740dd3dadbcd	0002-7335	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	19870401		NDA	NDA019640	Eli Lilly and Company
0002-7501_86761cc7-ee40-4d33-b4f2-fe6c81900a77	0002-7501	HUMAN PRESCRIPTION DRUG	Gemzar		Gemcitabine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19960522		NDA	NDA020509	Eli Lilly and Company	GEMCITABINE HYDROCHLORIDE	200	mg/5mL	Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
0002-7502_86761cc7-ee40-4d33-b4f2-fe6c81900a77	0002-7502	HUMAN PRESCRIPTION DRUG	Gemzar		Gemcitabine hydrochloride	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	19960522		NDA	NDA020509	Eli Lilly and Company	GEMCITABINE HYDROCHLORIDE	1	g/25mL	Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC]
0002-7510_43c17619-6d90-4656-b49c-9eae2e82fdf0	0002-7510	HUMAN PRESCRIPTION DRUG	Humalog		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19960724		NDA	NDA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-7511_26baf9da-de26-4838-9fe9-7323015c3ce3	0002-7511	HUMAN PRESCRIPTION DRUG	Humalog	Mix75/25	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	19991222		NDA	NDA021017	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-7512_cc3e0660-768c-411e-8f17-f39429c21aa9	0002-7512	HUMAN PRESCRIPTION DRUG	Humalog	Mix50/50	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	20060207		NDA	NDA021018	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-7516_43c17619-6d90-4656-b49c-9eae2e82fdf0	0002-7516	HUMAN PRESCRIPTION DRUG	Humalog		Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	19980220		NDA	NDA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-7597_ef1ff1d3-09be-47ef-89a2-c7494215be74	0002-7597	HUMAN PRESCRIPTION DRUG	ZYPREXA	Intramuscular	Olanzapine	INJECTION, POWDER, FOR SOLUTION	INTRAMUSCULAR	20040401		NDA	NDA021253	Eli Lilly and Company	OLANZAPINE	10	mg/2mL	Atypical Antipsychotic [EPC]
0002-7623_f4d59004-f7fb-430d-a9ef-e89c97d5b2ad	0002-7623	HUMAN PRESCRIPTION DRUG	Alimta		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20040213		NDA	NDA021462	Eli Lilly and Company	PEMETREXED DISODIUM HEPTAHYDRATE	500	mg/20mL	Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
0002-7635_35d0bf2e-75d6-4077-8690-cb2f0a54af82	0002-7635	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20100301		NDA	NDA022173	Eli Lilly and Company
0002-7636_35d0bf2e-75d6-4077-8690-cb2f0a54af82	0002-7636	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20100301		NDA	NDA022173	Eli Lilly and Company
0002-7637_35d0bf2e-75d6-4077-8690-cb2f0a54af82	0002-7637	HUMAN PRESCRIPTION DRUG	ZYPREXA	Relprevv	Olanzapine pamoate	KIT	INTRAMUSCULAR	20100301		NDA	NDA022173	Eli Lilly and Company
0002-7640_f4d59004-f7fb-430d-a9ef-e89c97d5b2ad	0002-7640	HUMAN PRESCRIPTION DRUG	Alimta		Pemetrexed disodium	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION	INTRAVENOUS	20080115		NDA	NDA021462	Eli Lilly and Company	PEMETREXED DISODIUM HEPTAHYDRATE	100	mg/4mL	Folate Analog Metabolic Inhibitor [EPC],Folic Acid Metabolism Inhibitors [MoA]
0002-7669_650ae8c4-8b68-449e-abf0-ed0dea269cba	0002-7669	HUMAN PRESCRIPTION DRUG	CYRAMZA		ramucirumab	SOLUTION	INTRAVENOUS	20140421		BLA	BLA125477	Eli Lilly and Company	RAMUCIRUMAB	10	mg/mL	Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC],VEGFR2 Inhibitors [MoA]
0002-7678_650ae8c4-8b68-449e-abf0-ed0dea269cba	0002-7678	HUMAN PRESCRIPTION DRUG	CYRAMZA		ramucirumab	SOLUTION	INTRAVENOUS	20140421		BLA	BLA125477	Eli Lilly and Company	RAMUCIRUMAB	10	mg/mL	Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC],VEGFR2 Inhibitors [MoA]
0002-8031_6ec7d335-6b45-42a0-8fe6-7e2f53e23758	0002-8031	HUMAN PRESCRIPTION DRUG	Glucagon		glucagon	KIT		19990301		NDA	NDA020928	Eli Lilly and Company
0002-8147_fcd69bec-865d-4403-882a-740dd3dadbcd	0002-8147	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20060127		NDA	NDA019640	Eli Lilly and Company
0002-8148_fcd69bec-865d-4403-882a-740dd3dadbcd	0002-8148	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20060127		NDA	NDA019640	Eli Lilly and Company
0002-8149_fcd69bec-865d-4403-882a-740dd3dadbcd	0002-8149	HUMAN PRESCRIPTION DRUG	HUMATROPE		Somatropin	KIT	INTRAMUSCULAR; SUBCUTANEOUS	20060127		NDA	NDA019640	Eli Lilly and Company
0002-8215_f2922cbb-e32e-4de5-9ee3-38ba48ab02ab	0002-8215	HUMAN OTC DRUG	Humulin	R	Insulin human	INJECTION, SOLUTION	PARENTERAL	19830627		NDA	NDA018780	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
0002-8315_43ffc8cd-73cc-4f98-89b5-f01f29714eb6	0002-8315	HUMAN OTC DRUG	Humulin	N	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	19830627		NDA	NDA018781	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
0002-8400_6b0cdd44-214a-4fa2-8f1a-9dc7f567d448	0002-8400	HUMAN PRESCRIPTION DRUG	Forteo		Teriparatide	INJECTION, SOLUTION	SUBCUTANEOUS	20081001		NDA	NDA021318	Eli Lilly and Company	TERIPARATIDE	250	ug/mL	Parathyroid Hormone [Chemical/Ingredient],Parathyroid Hormone Analog [EPC]
0002-8501_56852e9d-9832-4a7e-a19f-7ae855017bd6	0002-8501	HUMAN PRESCRIPTION DRUG	Humulin	R U-500	Insulin human	INJECTION, SOLUTION	SUBCUTANEOUS	19970106		NDA	NDA018780	Eli Lilly and Company	INSULIN HUMAN	500	[iU]/mL	Insulin [Chemical/Ingredient],Insulin [EPC]
0002-8715_48f9ae8b-b552-4a0b-bdba-8fe0f69b4aad	0002-8715	HUMAN OTC DRUG	Humulin	70/30	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	19890626		NDA	NDA019717	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
0002-8730_43ffc8cd-73cc-4f98-89b5-f01f29714eb6	0002-8730	HUMAN OTC DRUG	Humulin	N	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	19990201	20151031	NDA	NDA018781	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
0002-8770_48f9ae8b-b552-4a0b-bdba-8fe0f69b4aad	0002-8770	HUMAN OTC DRUG	Humulin	70/30	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	19990201	20151031	NDA	NDA019717	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
0002-8797_26baf9da-de26-4838-9fe9-7323015c3ce3	0002-8797	HUMAN PRESCRIPTION DRUG	Humalog	Mix75/25 KwikPen	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	20080116		NDA	NDA021017	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-8798_cc3e0660-768c-411e-8f17-f39429c21aa9	0002-8798	HUMAN PRESCRIPTION DRUG	Humalog	Mix50/50 KwikPen	Insulin lispro	INJECTION, SUSPENSION	SUBCUTANEOUS	20060207		NDA	NDA021018	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-8799_43c17619-6d90-4656-b49c-9eae2e82fdf0	0002-8799	HUMAN PRESCRIPTION DRUG	Humalog	KwikPen	Insulin lispro	INJECTION, SOLUTION	INTRAVENOUS; SUBCUTANEOUS	20080116		NDA	NDA020563	Eli Lilly and Company	INSULIN LISPRO	100	[iU]/mL	Insulin [Chemical/Ingredient],Insulin Analog [EPC]
0002-8803_48f9ae8b-b552-4a0b-bdba-8fe0f69b4aad	0002-8803	HUMAN OTC DRUG	Humulin	70/30	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	20131107		NDA	NDA019717	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
0002-8805_43ffc8cd-73cc-4f98-89b5-f01f29714eb6	0002-8805	HUMAN OTC DRUG	Humulin	N	Insulin human	INJECTION, SUSPENSION	SUBCUTANEOUS	20131107		NDA	NDA018781	Eli Lilly and Company	INSULIN HUMAN	100	[iU]/mL
